Bitcoin
71153.93
-1529.33
-2.15%
Crude Oil
80.25
+5.59
+6.97%
Gold
5086.5
-48.2
-0.95%
Copper
5.82
-0.09
-1.55%
Silver
82.16
-1.02
-1.25%
Dow Jones
48739.42
+238.14
+0.49%
SP500
6815.04
-54.46
-0.8%
NASDAQ
22807.48
+290.79
+1.27%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
80
+99.00%
Top Gainers
1,648,107
Top Gainers
3.45
+99.00%
Top Gainers
162,203
Top Gainers
29.79
+95.43%
Top Gainers
9,432,762
Top Gainers
40.79
+95.27%
Top Gainers
145,434,680
Top Gainers
44.97
+90.79%
Top Gainers
4,714,644
Top Gainers
43.17
+90.20%
Top Gainers
337,965
Top Gainers
2.245
+82.48%
Top Gainers
212,552
Top Gainers
10.49
+48.52%
Top Gainers
170,650
Top Gainers
3.99
+34.84%
Top Gainers
630,562
Top Gainers
11.9
+30.00%
Top Gainers
291,980
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
261
-391.95%
Top Loosers
926,457
Top Loosers
8.82
-161.56%
Top Loosers
215,283
Top Loosers
1.1
-55.45%
Top Loosers
524,062
Top Loosers
755
-42.78%
Top Loosers
452,624
Top Loosers
6.295
-39.63%
Top Loosers
1,273,554
Top Loosers
5.395
-37.44%
Top Loosers
748,963
Top Loosers
2.07
-36.23%
Top Loosers
34,011,413
Top Loosers
5.8989
-35.11%
Top Loosers
2,173,064
Top Loosers
4.01
-34.91%
Top Loosers
203,106
Top Loosers
4.2079
-25.72%
Top Loosers
770,832
Top Loosers

In Today's Headlines

Six Flags to sell 7 amusement parks in deal worth more than $330M
03:35
05 Mar 2026
Six Flags to sell 7 amusement parks in deal worth more than $330M

Six Flags will sell seven amusement parks for $331 million, including Michigan's Adventure and Valleyfair, to focus on stronger-performing locations.

Okta shares rally on strong earnings as Jefferies analysts see room for revenue upside
03:31
05 Mar 2026
Okta shares rally on strong earnings as Jefferies analysts see room for revenue upside

Okta Inc (NASDAQ:OKTA)'s latest quarterly results showed solid growth in key metrics, with analysts at Jefferies highlighting that the company appears to be prioritizing accelerating revenue growth even if it comes at the expense of near-term margins. In a note following the results, Jefferies maintained a ‘Buy' rating on the identity management company and a $105 price target.

Amazon down for thousands of users in US, Downdetector shows
03:29
05 Mar 2026
Amazon down for thousands of users in US, Downdetector shows

Amazon was down ​for thousands of ‌users on Thursday, according ​to Downdetector.com.

Examining Historical CLO Equity Returns With ECC
03:28
05 Mar 2026
Examining Historical CLO Equity Returns With ECC

Eagle Point Credit (ECC) and other CLO equity CEFs have suffered recent price declines, but NAV returns remain broadly consistent with historical CLO equity performance. Premium/discount swings in CEFs, not underlying asset performance, have driven the disconnect between market price returns and NAV returns for funds like ECC and XFLT. Active CEF rotation—buying at wide discounts and rotating out at premiums—has historically generated alpha and mitigated losses, especially during volatile markets.

Why Corning Is A Buy: The Glass Giant Now Fuels The AI Revolution
03:26
05 Mar 2026
Why Corning Is A Buy: The Glass Giant Now Fuels The AI Revolution

Corning has evolved from an industrial materials company into a key enabler of AI infrastructure. As fiber optics becomes a critical chokepoint in AI development, GLW stands out as one of the few companies able to meet global demand, justifying its premium stock price. The company is a high-risk, high-reward stock.

Akamai Technologies, Inc. (AKAM) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
03:25
05 Mar 2026
Akamai Technologies, Inc. (AKAM) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Akamai Technologies, Inc. (AKAM) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Cash Flow Kings: 2 Stocks to Hide In, 1 to Avoid
03:22
05 Mar 2026
Cash Flow Kings: 2 Stocks to Hide In, 1 to Avoid

In today's markets, where macroeconomic concerns, fears centered on AI spending and disruption, inflation, and interest rates weigh on performance, cash flow is king. Companies that produce revenue and, more importantly, free cash flow and profits, are being rewarded while those that aren't get punished.

YieldMax® HIMS Option Income Strategy ETF (HIYY) Trading Halt
03:19
05 Mar 2026
YieldMax® HIMS Option Income Strategy ETF (HIYY) Trading Halt

MILWAUKEE, March 05, 2026 (GLOBE NEWSWIRE) -- Tidal Investments LLC (“Tidal”) announces that the YieldMax® HIMS Option Income Strategy ETF (NYSE Arca: HIYY) was halted to allow Tidal to evaluate the accuracy of the HIYY Net Asset Values per share (NAVs) published for March 2, 3, and 4, 2026. Tidal determined the NAV for HIYY was required to be restated on March 2 from $12.38 per share to $12.15 per share, on March 3 from $9.92 per share to $11.81 per share and on March 4 from $10.24 per share to $12.13 per share.

Leverage Broadcom Guidance Beat and Nvidia OpenAI Strategy
03:17
05 Mar 2026
Leverage Broadcom Guidance Beat and Nvidia OpenAI Strategy

The semiconductor industry remains the epicenter of market volatility and growth in 2026 thanks to an insatiable demand for hardware as the artificial intelligence (AI) buildout continues.

Robbins LLP Urges INO Stockholders Who Lost Money Investing in Inovio Pharmaceuticals, Inc. to Contact the Firm for Information About Leading the Class Action
03:17
05 Mar 2026
Robbins LLP Urges INO Stockholders Who Lost Money Investing in Inovio Pharmaceuticals, Inc. to Contact the Firm for Information About Leading the Class Action

SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”).